健康管理模板

No.

API Name

CAS NO.

Indication

Spec.

Stage

21462-39-5

FDA /CP/ CEP/USP

Clindamycin Phosphate

24729-96-2

Anti-infection

FDA /CP/CEP/USP

Commercial

Amphotericin B (Oral & Injection)

1397-89-3

Antifungal

CP/EP/USP

Commercial

Clindamycin Palmitate Hydrochloride

Anti-infection

CP/EP/USP

Commercial

138112-76-2

Anti-depression

INH

Commercial

4618-18-2

PV     

Anti-depression

PV     

Netupitant

290297-26-6

Prevent Vomiting

R&D   

Fosnetupitant

R&D   

Anidulafungin

166663-25-8

R&D   

R&D   

Carboprost Tromethamine

58551-69-2

Pregnancy Termination

R&D   

No.

Intermediate Name

CAS No.

7-Methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate

Constructing core structure of EGFR inhibitors.   

Methyl-d3-amine hydrochloride

7436-22-8

tert-Butyl (4R-cis)-6-Chloromethyl-2,2-dimethyl-1,3-dioxane-4-acetate

154026-94-5

Starting material of Rosuvastatin Calcium

tert-Butyl (4R-cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetate

154026-95-6

(R)-(+)-1-Boc-3-aminopyrrolidine

147081-49-0

For Ceftobiprole, Sunvozertinib, etc.

tert-butyl 4-(6-aminopyridin-3-yl)piperidine-1-carboxylate

1198408-35-3

Building Block.

508233-74-7

Intermediate of Vortioxetine

Vortioxetine Hydrochloric

Di-tert-butyl Chloromethyl Phosphate

229625-50-7

Intermediate of Fosnetupitant

N-tert-butyl-6-chloro-4-(o-tolyl)nicotinamide

Intermediate of Netupitant and Fosnetupitant

Methyl-[6-(4-methyl-piperazin-1-yl)-4-o-tolyl-pyridin-3-yl]-amine

(S)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionic acid

24435-45-8

Building Block

(4-(2-(dimethylamino)ethoxy)phenyl)(4-hydroxyphenyl)methanone

173163-13-8

Building Block

Chiral catalyst

(R)-2-(diphenylmethyl)pyrrolidine

22348-31-8

Cosmetic & Health Product Efficacious Ingredients

Name

CAS No.

96702-03-3

Commercial

19132-12-8

R&D

N-Acetyl-L-Carnosine

R&D